
The efficacy of the zzso zzso zzso product containing zzso and zzso zzso applied once daily in psoriasis has been demonstrated in phase III trials but no zzso clinical trial comparing all commonly used topical treatments zzso The aim of the study was to compare the efficacy of zzso use of the zzso product relative to other commonly used topical agents in plaque zzso 

Data on change in zzso Area and zzso Index zzso score from baseline and zzso 75 zzso of patients achieving a zzso reduction in zzso zzso after 4 weeks of treatment were obtained by means of a systematic literature review of zzso controlled trials and zzso with a zzso mixed treatment comparison zzso 

Relative to all active interventions, except for the zzso zzso application of the zzso product, the zzso once daily showed a greater efficacy based on zzso 75 response zzso risk ranging from zzso to zzso and improvement in zzso score from baseline zzso in % zzso zzso between zzso once daily and other active interventions ranged from zzso to zzso 

Among topical therapies zzso zzso once daily can be considered the most zzso treatment for plaque zzso 

